Openbookopenbook
Equity
VREX
+0.0 · +0.00%
USD · NASDAQ

Varex Imaging Corp(VREX) Stock Analysis | Healthcare

USD --+0.00%
Reward42Moderate
Risk55Medium-High
75%Data
Thin 3% profit margin
Profitless Growth
Market Cap:779.74M
ⓘ
Reward Rating
42
Moderate
Reward Assessment
75% data coverage
Bottom 10% of stocksView factors
ⓘ
Risk Rating
55
Medium-High
Risk Assessment
4 metrics flaggedView details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on VREX to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for VREX, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $18.93.

What is Varex Imaging Corp?

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components.

VREX · Verdict

Moderate reward · elevated risk

VREX has limited near-term tailwinds — valuation and profitability weigh on the model output.

Based on 88% data coverage

VREX · Verdict

What’s working & what to watch

Watchouts 4

  • Valuation24/100

    P/E 20.3× · PEG 6.30

  • Profitability25/100

    -8% net margin · 5% ROE

  • Balance sheet36/100

    Net debt/EBITDA 73.4×

  • Cash flow44/100

    2% free-cash-flow margin

Model-based scoring. For information only — not financial advice.

What is Varex Imaging Corp?

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 779.74M, and a P/E ratio of 34.9x.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Moderate volatility with meaningful macro and earnings sensitivity.
Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (42)

The scoring profile indicates limited reward potential at this time, with growth and momentum offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Medical Devices names that are close enough in size to make side-by-side comparison useful.

SSIISmall Cap / 779M market cap
SS Innovations International Inc. Common Stock
Compare
AHCOSmall Cap / 751M market cap
Adapthealth Corp
Compare
MROPFSmall Cap / 823M market cap
MicroPort CardioFlow Medtech Corporation
Compare
Company Information
SectorHealthcare
IndustryMedical Devices
Market Cap779.74M
P/E Ratio34.9057
Dividend YieldN/A
Beta0.877
Insider Activity
12M windowQuiet
Fewer than three real open-market insider trades in the last 12 months. Mechanical activity (option exercises, RSU vests) is excluded from the signal.
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.